1. Home
  2. TXMD vs DSS Comparison

TXMD vs DSS Comparison

Compare TXMD & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXMD
  • DSS
  • Stock Information
  • Founded
  • TXMD 2008
  • DSS 1984
  • Country
  • TXMD United States
  • DSS United States
  • Employees
  • TXMD N/A
  • DSS N/A
  • Industry
  • TXMD Biotechnology: Pharmaceutical Preparations
  • DSS Containers/Packaging
  • Sector
  • TXMD Health Care
  • DSS Consumer Discretionary
  • Exchange
  • TXMD Nasdaq
  • DSS Nasdaq
  • Market Cap
  • TXMD 12.3M
  • DSS 11.7M
  • IPO Year
  • TXMD N/A
  • DSS N/A
  • Fundamental
  • Price
  • TXMD $1.19
  • DSS $1.13
  • Analyst Decision
  • TXMD
  • DSS
  • Analyst Count
  • TXMD 0
  • DSS 0
  • Target Price
  • TXMD N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • TXMD 511.6K
  • DSS 60.0K
  • Earning Date
  • TXMD 11-12-2025
  • DSS 11-14-2025
  • Dividend Yield
  • TXMD N/A
  • DSS N/A
  • EPS Growth
  • TXMD N/A
  • DSS N/A
  • EPS
  • TXMD N/A
  • DSS N/A
  • Revenue
  • TXMD $2,559,000.00
  • DSS $21,252,000.00
  • Revenue This Year
  • TXMD $427.09
  • DSS N/A
  • Revenue Next Year
  • TXMD N/A
  • DSS N/A
  • P/E Ratio
  • TXMD N/A
  • DSS N/A
  • Revenue Growth
  • TXMD 156.93
  • DSS 10.24
  • 52 Week Low
  • TXMD $0.70
  • DSS $0.72
  • 52 Week High
  • TXMD $2.44
  • DSS $1.90
  • Technical
  • Relative Strength Index (RSI)
  • TXMD 53.55
  • DSS 34.13
  • Support Level
  • TXMD $1.19
  • DSS $1.11
  • Resistance Level
  • TXMD $1.28
  • DSS $1.30
  • Average True Range (ATR)
  • TXMD 0.13
  • DSS 0.09
  • MACD
  • TXMD 0.01
  • DSS -0.03
  • Stochastic Oscillator
  • TXMD 23.88
  • DSS 5.88

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: